IGM Biosciences is pioneering a new class of antibody medicines for the treatment of cancer and autoimmune and inflammatory diseases. Building upon the greater binding power provided by the naturally occurring IgM antibody structure, as compared with the commonly used IgG antibody structure, IGM has been able to create “super antibodies” with the potential to generate novel therapeutic options and hope for patients.

» LEARN MORE ABOUT WHAT SETS US APART

Reimagining antibody medicines

We believe we have the world’s most advanced research and development program focused on engineered therapeutic IgM antibodies.

Using our expertise to expand upon and improve the inherent qualities of IgM antibodies and produce them at scale, we aim to develop a range of therapeutic antibodies for the treatment of cancer and autoimmune and inflammatory diseases.

» READ MORE ABOUT OUR PLATFORM

Exploring scientific boundaries

By developing this new class of antibodies,
we have opened up new approaches to treating disease.

» Learn more about our lead programs

Make an impact at IGM

Help us bring a new class of antibody medicines to patients.

» LEARN MORE ABOUT BEING PART OF THE IGM TEAM